Atlas Trials

Exploration of the Value of PSMA PET/CT in Dynamic Monitoring of the Efficacy of Novel Endocrine Therapy in Patients With Metastatic Hormone Sensitive Prostate Cancer

Clinical trial NCT06387238 · UNKNOWN

Trial details

NCT number
NCT06387238
Sponsor
Peking University First Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Adenocarcinoma
Start date
2024-05-01
Primary completion
2025-05-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.